20 "Past Their Prime" Stocks to Dump From Your Portfolio - 20 of 20 Slide 20Back to 19Next Slideshow Back to 19Next Slideshow Roivant Sciences (NASDAQ:ROIV)Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. Read More Trailing Twelve Months EPS: $5.562024 EPS Estimate: ($1.14)2025 EPS Estimate: ($1.25)Current Stock Price $11.78P/E Ratio 2.1Consensus Rating Moderate BuyRatings Breakdown 9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.Consensus Price Target $17.39 (47.6% Upside)More Investing Slideshows:7 Dividend Achievers That Have Strong Upside7 Stocks That Hold Appeal for Aggressive Investors7 High-Yield Dividend Stocks Outperforming 10-Year Treasuries7 Tech Stocks That Still Offer Good Value for 20257 Long-Term Stocks to Own Regardless of the Election Outcome7 Gold Stocks to Buy as the Metal Hits an All-Time High7 Stocks with Recent Downgrades Worth a Second Look7 Chip Stocks to Buy on the DipBetting on a Santa Claus Rally? Consider These 7 Risk-On Stocks7 of the Best Long-Term Stocks to BuySlide 20Back to 19Next Slideshow Did you miss 1000% bitcoin gains? (Ad)Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Because a new blockchain is taking the world by storm… It’s seeing rapid adoption amongst crypto fans… And just now starting to break into the mainstream. While I cannot promise future returns or against losses… This might not just be another chance at Bitcoin-like gains… It could be EVEN bigger. But this market is moving fast… So if you want a shot at getting in on what could be the ground floorClick Here for Details.More From MarketBeatBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored7 Low Beta Stocks for the Risk-Averse InvestorInvesting is about balancing risk and reward. That's why regardless of market conditions, many investors with ...MarketBeatThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored13 Stocks With Strong Institutional BuyingHedge funds, university endowments, pension funds, and sovereign wealth funds have been pouring money into an ...MarketBeat625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored7 Best Growth Stocks for the Next 10 YearsIf you're somewhat new to investing, the term “growth stocks" may be confusing. After all, don't you wan...MarketBeat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Slide 20Back to 19Next Slideshow Back to 19Next Slideshow Roivant Sciences (NASDAQ:ROIV)Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. Read More Trailing Twelve Months EPS: $5.562024 EPS Estimate: ($1.14)2025 EPS Estimate: ($1.25)Current Stock Price $11.78P/E Ratio 2.1Consensus Rating Moderate BuyRatings Breakdown 9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.Consensus Price Target $17.39 (47.6% Upside)More Investing Slideshows:7 Dividend Achievers That Have Strong Upside7 Stocks That Hold Appeal for Aggressive Investors7 High-Yield Dividend Stocks Outperforming 10-Year Treasuries7 Tech Stocks That Still Offer Good Value for 20257 Long-Term Stocks to Own Regardless of the Election Outcome7 Gold Stocks to Buy as the Metal Hits an All-Time High7 Stocks with Recent Downgrades Worth a Second Look7 Chip Stocks to Buy on the DipBetting on a Santa Claus Rally? Consider These 7 Risk-On Stocks7 of the Best Long-Term Stocks to BuySlide 20Back to 19Next Slideshow Did you miss 1000% bitcoin gains? (Ad)Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Because a new blockchain is taking the world by storm… It’s seeing rapid adoption amongst crypto fans… And just now starting to break into the mainstream. While I cannot promise future returns or against losses… This might not just be another chance at Bitcoin-like gains… It could be EVEN bigger. But this market is moving fast… So if you want a shot at getting in on what could be the ground floorClick Here for Details.More From MarketBeatBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored7 Low Beta Stocks for the Risk-Averse InvestorInvesting is about balancing risk and reward. That's why regardless of market conditions, many investors with ...MarketBeatThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored13 Stocks With Strong Institutional BuyingHedge funds, university endowments, pension funds, and sovereign wealth funds have been pouring money into an ...MarketBeat625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored7 Best Growth Stocks for the Next 10 YearsIf you're somewhat new to investing, the term “growth stocks" may be confusing. After all, don't you wan...MarketBeat
